A Trial of SHR8735 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 11, 2021

Primary Completion Date

July 15, 2021

Study Completion Date

July 15, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

SHR8735

SHR8735 is an thrombopoietin receptor agonist to promote platelet production.

Trial Locations (1)

Linear Clinical research, Perth

All Listed Sponsors

lead

Atridia Pty Ltd.

INDUSTRY

NCT04701216 - A Trial of SHR8735 in Healthy Subjects | Biotech Hunter | Biotech Hunter